Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 14 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 11382899

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  2. US 11376324

    Sting activating nanovaccine for immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  3. US 11377491

    Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  4. US 11370757

    Photocleavable nitroindoline-based crosslinkers

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  5. US 11369716

    Reparative cell isolation and delivery

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  6. US 11370786

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  7. US 11365183

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  8. US 11365413

    Inhibition of poly(A) binding protein and the treatment of pain

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  9. US 11365189

    Heterocyclic inhibitors of tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  10. US 11364197

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  11. US 11365250

    Compositions and methods for cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  12. US 11358991

    Heme sequesting peptides and uses therefor

    The Board of Regents of the University of Texas System · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  13. US 11345659

    Pipecolic esters for inhibition of the proteasome

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  14. US 11344578

    Immune cells expressing engineered antigen receptors

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  15. US 11344577

    Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  16. US 11331333

    Treatment of aberrant fibroblast proliferation

    The Board of Regents of the University of Texas System · Granted May 17, 2022 · Expires May 12, 2042

    granted
  17. US 11332483

    Naphthoquinone containing gold carbene complexes and methods of uses thereof

    The Board of Regents of the University of Texas System · Granted May 17, 2022 · Expires May 12, 2042

    granted
  18. US 11325898

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted May 10, 2022 · Expires May 5, 2042

    granted
  19. US 11318186

    Use of FGF21 in methods of increasing exocrine pancreatic secretion

    The Board of Regents of the University of Texas System · Granted May 3, 2022 · Expires Apr 28, 2042

    granted
  20. US 11313868

    Methods of detecting anti-folic acid antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted
  21. US 11304916

    Methods and compositions for the treatment of Shiga Toxicosis

    The Board of Regents of the University of Texas System · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  22. US 11304911

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  23. US 11299512

    Cyclic di-nucleotide compounds and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  24. US 11293024

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted